Brief: Viveve Medical Announced Positive Primary Efficacy Data From Its Three-Arm, Five-Month Stress Urinary Incontinence Feasibility Study
Aug 25 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE MEDICAL - ANNOUNCED POSITIVE PRIMARY EFFICACY DATA
FROM
ITS THREE-ARM, FIVE-MONTH STRESS URINARY INCONTINENCE (SUI)
FEASIBILITY STUDY
* VIVEVE - POSITIVE OUTCOMES FROM IN-VIVO PRECLINICAL STUDY
CONDUCTED TO VALIDATE ITS NEW INERT SHAM TIP FOR USE IN PIVOTAL
PURSUIT TRIAL IN U.S.
Source: (https://bit.ly/2QmDaDh)
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq